How do pharmaceutical companies find good agent products?

For example, it is a good development trend for pharmaceutical commercial companies to vigorously expand the original "general agent" business. Therefore, finding a good product to be the national general agent has become the top priority of all work. So how can we find a long-term variety with high profit, exclusive or patent protection and easy to win the bid? The author here provides some reference operation methods for everyone. First of all, a pharmaceutical company located in this development direction can set up a special variety screening and negotiation team, whose members can be part-time members of the company's internal marketing department or other departments. Its key tasks are: monitoring the drug approval and evaluation status of the National Drug Evaluation Center at any time; Regularly contact large domestic pharmaceutical R&D companies, research groups of pharmaceutical colleges and universities, Chinese Academy of Sciences, Academy of Military Medical Sciences and other well-known pharmaceutical research institutions for information on project establishment, varieties being reported, transfer trends and intended buyers of research projects. Doing this kind of work well can help the pharmaceutical general agent company to grasp the drug listing information in the next 3-5 years from the source, and also provide a lot of alternative opportunities for negotiating the national general agent, because the agency rights of really good varieties have been negotiated or signed since the project was established, and the variety agents with the document number can only act as the market supplement of the last general agent. It can be said that "the victory or defeat of the war was actually decided before the war." Secondly, we should actively contact the headquarters of well-known multinational pharmaceutical companies and their Asia-Pacific market business departments and other institutions, and actively negotiate the general agency rights of some leading drugs of these multinational companies in China, such as Shenzhen Jian 'an Medicine, Pioneer Medicine and Livzon Medicine, which started and developed in this mode in the 199s in China, and this mode is also very common in the world, such as Yongyu Medicine, Jebsen Foreign Firm and Livzon Medicine. Third, we should actively contact and negotiate with large domestic pharmaceutical companies. In recent years, many large pharmaceutical companies have submitted for approval or are reporting many varieties, and small and medium-sized pharmaceutical companies can sign general agency rights with them in advance. Such typical pharmaceutical companies include: Hengrui Pharmaceutical, Huabei Pharmaceutical and Wuhan Jianmin Pharmaceutical. Typical representatives of this agency model are: Shenzhen Longou Medicine, Jiangsu Kefeiping Medicine, etc. If this kind of general agent product is a Chinese medicine product, it is often very competitive, either a protected variety of Chinese medicine or an exclusive variety, which has taken the advantage in bidding. It is such a model that "Beijing Yongzheng Medicine" always replaces "Xiaojin Capsule" and "Convenient Capsule" of "Wuhan Jianmin Pharmaceutical" to distribute the whole country through investment promotion. Fourth, small and medium-sized pharmaceutical companies can also actively discuss the second-line products of domestic joint ventures and wholly-owned multinational pharmaceutical companies. These products are often domestic exclusive or patented varieties, which have unique advantages in pricing, bidding and even entering hospitals. These varieties are beyond the care of the self-built sales teams of these multinational pharmaceutical companies. Therefore, once these products have obtained the general agency rights, they are generally long-term products. Because these products need long-term academic promotion, the general agent should have enough. In fact, the sales model of this kind of products is almost equivalent to the practice of manufacturers building their own teams. Whether it is the establishment of sales teams or the establishment and application of expert networks, all a series of academic promotion work needs to be completed by the general agent. The typical representative of this model is "Yangpu Fahrenheit Pharmaceutical Company". For small and medium-sized pharmaceutical commercial companies, they can make up for the decline in profits caused by not obtaining the right to post-bid distribution by giving full play to their regional business advantages and expanding their regional drug distributor business. To be a general agent in a certain region, you can also learn from the above methods on how to find good products. In addition to your capital, talents and distribution strength, you also need the top management of the general agent company to make efforts to build up the personal connections in the industry. Because of the complicated interests in the negotiations, if they are unfamiliar customer relationships, the probability of successful agency relationships is limited after all. Such regional general agent pharmaceutical companies include "Chengdu Wanlong Yikang Medicine".